363, 2nd Floor, Industrial Area, Phase 2, Renault Showroom, Industrial Area Phase 2,, Panchkula, Haryana, India, Panchkula Haryana 134113 Send a message
Bn vn nn cn trng khi s dng bt c cng thc m phm no nu c tin s d ng, kch ng
Considerations of Subject Comfort TB-500 Nasal Spray: When considering administration methods, nasal sprays provide a non-invasive option for delivering TB-500
CagriSema vs Comparators Feature Receptor targets CagriSema Amylin/calcitonin + GLP-1 Tirzepatide (Zepbound) GIP + GLP-1 Semaglutide alone (Wegovy) GLP-1 Cagrilintide alone Amylin/calcitonin (DACRA) Feature Dosing frequency CagriSema Once weekly Tirzepatide (Zepbound) Once weekly Semaglutide alone (Wegovy) Once weekly Cagrilintide alone Once weekly Feature Maintenance dose CagriSema 2.4 mg + 2.4 mg Tirzepatide (Zepbound) Up to 15 mg Semaglutide alone (Wegovy) 2.4 mg Cagrilintide alone 2.4 mg (in REDEFINE arms) Feature Headline weight loss CagriSema 20.4% at 68 wks (REDEFINE 1, treatment-policy) Tirzepatide (Zepbound) Up to 22.5% at 72 wks (SURMOUNT-1, 15 mg arm) Semaglutide alone (Wegovy) 14.9% at 68 wks (REDEFINE 1 reference arm) Cagrilintide alone 11.5% at 68 wks (REDEFINE 1 reference arm) Feature FDA status (June 2026) CagriSema NDA filed Dec 2025
Thats fine for a mild cold, but if youre dealing with persistent mucus in the throat, chest, or lungs, you need something that actually targets the mucus itself
Johnson B, Kopetz S , Hwang H, Yuan Y, DePinho RA, Zebala J, Overman MJ
